Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A C Maple

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Pathology|March 1, 2003
Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infectionC S Jones, P A C Maple, N J Andrews, et al.
Epidemiology and Infection|August 28, 2015
Is it appropriate to use fixed assay cut-offs for estimating seroprevalence?G Kafatos, N J Andrews, K J McConway, et al.
Epidemiology and Infection|March 29, 2016
The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassayP A C Maple, J Haedicke, M Quinlivan, et al.
Vaccine|November 8, 2003
European Sero-Epidemiology Network: standardisation of the assay results for pertussisA Giammanco, A Chiarini, P A C Maple, et al.
Journal of Virological Methods|January 4, 2011
Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workersS L R McDonald, P A C Maple, N Andrews, et al.
Epidemiology and Infection|February 24, 2005
The seroepidemiology of Bordetella pertussis infection in Western EuropeR G Pebody, N J Gay, A Giammanco, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Pathology|March 1, 2003
Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infectionC S Jones, P A C Maple, N J Andrews, et al.
Epidemiology and Infection|August 28, 2015
Is it appropriate to use fixed assay cut-offs for estimating seroprevalence?G Kafatos, N J Andrews, K J McConway, et al.
Epidemiology and Infection|March 29, 2016
The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassayP A C Maple, J Haedicke, M Quinlivan, et al.
Vaccine|November 8, 2003
European Sero-Epidemiology Network: standardisation of the assay results for pertussisA Giammanco, A Chiarini, P A C Maple, et al.
Journal of Virological Methods|January 4, 2011
Evaluation of the time resolved fluorescence immunoassay (TRFIA) for the detection of varicella zoster virus (VZV) antibodies following vaccination of healthcare workersS L R McDonald, P A C Maple, N Andrews, et al.
Epidemiology and Infection|February 24, 2005
The seroepidemiology of Bordetella pertussis infection in Western EuropeR G Pebody, N J Gay, A Giammanco, et al.
Pageof 2